13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001085146-25-005241
Total Value
$260.1M
Positions
29
Other Managers
0
Confidential Omitted
No
Holdings (29)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SKYE BIOSCIENCE INC | SKYE | 9,913,168 | $41.4M | 15.93% |
| 2 | ENTRADA THERAPEUTICS INC | TRDA | 4,308,379 | $29.0M | 11.13% |
| 3 | DIANTHUS THERAPEUTICS INC | DNTH | 984,725 | $18.3M | 7.05% |
| 4 | ENLIVEN THERAPEUTICS INC | ELVN | 772,477 | $15.5M | 5.96% |
| 5 | PHARVARIS N V | PHVS | 797,600 | $14.0M | 5.40% |
| 6 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 282,313 | $13.3M | 5.12% |
| 7 | CENTESSA PHARMACEUTICALS PLC | CNTA | 830,945 | $10.9M | 4.20% |
| 8 | VOR BIOPHARMA INC | VOR | 6,361,723 | $10.3M | 3.96% |
| 9 | VIRIDIAN THERAPEUTICS INC | VRDN | 736,595 | $10.3M | 3.96% |
| 10 | TECTONIC THERAPEUTIC INC | TECX | 511,660 | $10.2M | 3.91% |
| 11 | CELLDEX THERAPEUTICS INC NEW | CLDX | 497,270 | $10.1M | 3.89% |
| 12 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,050,000 | $9.9M | 3.80% |
| 13 | TYRA BIOSCIENCES INC | TYRA | 939,298 | $9.0M | 3.46% |
| 14 | PRAXIS PRECISION MEDICINES I | PRAX | 170,000 | $7.1M | 2.75% |
| 15 | GH RESEARCH PLC | GHRS | 572,665 | $7.0M | 2.68% |
| 16 | ERASCA INC | ERAS | 5,405,404 | $6.9M | 2.64% |
| 17 | BIOHAVEN LTD | BHVN | 478,972 | $6.8M | 2.60% |
| 18 | VIKING THERAPEUTICS INC | VKTX | 189,593 | $5.0M | 1.93% |
| 19 | SCPHARMACEUTICALS INC | 810648105 | 1,200,647 | $4.6M | 1.76% |
| 20 | CAMP4 THERAPEUTICS CORP | CAMP | 2,927,915 | $4.2M | 1.63% |
| 21 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 2,353,304 | $3.6M | 1.37% |
| 22 | SURROZEN INC | SRZNW | 310,000 | $2.8M | 1.07% |
| 23 | SILENCE THERAPEUTICS PLC | SLNCF | 476,200 | $2.8M | 1.06% |
| 24 | PROTARA THERAPEUTICS INC | TARA | 800,000 | $2.4M | 0.93% |
| 25 | ALECTOR INC | ALEC | 995,841 | $1.4M | 0.54% |
| 26 | RALLYBIO CORP | RLYB | 3,630,724 | $1.2M | 0.47% |
| 27 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 541,666 | $1.2M | 0.45% |
| 28 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 490,000 | $568,400 | 0.22% |
| 29 | MERSANA THERAPEUTICS INC | 59045L106 | 1,305,000 | $386,280 | 0.15% |